Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease
Clinical trial NCT06260059 · RECRUITING
Trial details
- NCT number
- NCT06260059
- Sponsor
- Anita Saraf
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-17
- Primary completion
- 2026-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.